DaVita Stock Declines 1.2% in 3 Months: Here's How to Play

DaVita Inc.’s (DVA) investors have been experiencing some short-term losses of late. Shares of this Denver, CO-based comprehensive kidney care provider have lost 1.2% in the past three months in contrast to the industry and the sector’s 2.6% and 1.1% gains, respectively. The stock has, however, outperformed the S&P 500’s 3.6% decline.A major development at DVA in recent months was the announcement of its promising fourth-quarter 2024 results in February. The company reported robust improvement in the top an ...